CONSULTING AGREEMENTConsulting Agreement • May 14th, 2021 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances
This Consulting Agreement (“Agreement”) confirms the understanding between David Schreiber (“Schreiber”) and Aspira Womens Health (“Company”) pursuant to which the Company has retained Schreiber to provide consulting services of the type described below (collectively, the “Services”), on the terms and subject to the conditions set forth herein, in connection with the matters referred to herein.
